Author

Guenka Petrova

Observed names: G Petrova, Petrova, Guenka

Institution: Medical University of Sofia

Observed institution: Medical University of Sofia

ORCID: 0000-0001-8116-5138

Observed ORCID: 0000-0001-8116-5138

OpenAlex ID: A5123888067

Transferability of Real World Evidence to Support HTA Recommendations in Lower Income European Countries

2026 · Zoltán Kaló, Guenka Petrova, et al. · Health Science Reports · 4

European Network on Optimizing Treatment With Therapeutic Antibodies in Chronic Inflammatory Diseases: Overview, Progress and Perspectives

2026 · Konstantin Tachkov, Merita Rumano, et al. · Clinical and Translational Science · 1

Pharmacoeconomic analysis of bromhexine for prophylactic of influenza A and B

2026 · Guenka Petrova, Vanyo Mitev · Pharmacia · 1

Features of mobile health applications (mHealth apps) for asthma

2026 · Petar Nikolov, Guenka Petrova · Pharmacia · 1

Developing a national digital platform for detecting potentially inappropriate medications: adaptation of the EU(7)-PIM list to Bulgarian healthcare practice

2026 · Petya Milushewa, Guenka Petrova · Pharmacia · 1

The economic and social burden of obesity in Bulgaria

2026 · Sofiya Mihaylova, Guenka Petrova · Pharmacia

Recommendations to improve the evidence base of public health policies by transferring economic models of vaccination programs to lower income European countries

2026 · Zoltán Kaló, Jovan Mihajlović, et al. · Vaccine X

Pharmacoeconomic and healthcare consequences of TDM-guided decisions on biologic treatment of inflammatory diseases: a systematic review and meta-regression

2026 · Przemyslaw Holko, Katarzyna Sladowska, et al. · Research Square

Real-world effectiveness and economic evaluations of EMA-approved orphan medicines for spinal muscular atrophy: a systematic literature review

2026 · Neli Boseva-Stoyanova, Teodora Chamova, et al. · Pharmacia

Comparative analysis of prices, public expenditures, and utilization of biological disease modifying drugs for treatment of inflammatory joint diseases in Bulgaria and Serbia

2026 · Zornitsa Mitkova, Ana Stefanovic, et al. · Biotechnology & Biotechnological Equipment

Incorporating cost considerations into shared decision-making: A cross-country comparison among Hungary, France, and Bulgaria

2026 · Guenka Petrova, Maria Kamusheva, et al. · Pharmacia

EE8 Cost of Arthropathic Diseases Therapy: A 5-Year Budget Analysis at National Level

2022 · K Tachkov, V Boyadzhieva, et al. · Value in Health

Farmakoterapija arterijske hipertenzije u ambulantnim uslovima - troškovi na godišnjem nivou na teret sredstava zdravstvenog osiguranja

2009 · Andrić, Vesna, Lakić, Dragana, et al. · FarFar - Pharmacy Repository

Works count: 15

Citation count: 8

H-index: 1

I10-index: